YAFO Capital

Founded in 2013, YAFO Capital is a Shanghai based boutique investment & advisory firm focusing on bringing global technologies to Asia, especially China and Japan. We started from investing in Israeli Medtech to China back to 2013, now with a team of 20+ professionals in our China, U.S., Japan, and London offices. YAFO operates through its two divisions, YAFO Life Science (YLS) and YAFO Fund Management. We are a licensed asset manager in China.

YAFO, the Hebrew word of Jaffa (now part of Tel Aviv), means beautiful. For 3500 years, the old Jaffa port has connected the ancient city with the rest of the world.

YAFO’s mission is to make our life more beautiful by introducing global technologies.

YAFO Life Science – Bridging the Gap Between Global Biopharma & Medtech and Asia.

YAFO Life Science

YAFO Life Science (YLS) is the healthcare division of YAFO Capital, which is focused on helping leading U.S. and European biopharma and Medtech companies successfully enter the Asian market, especially China and Japan. YLS also helps domestic pharma companies in global market research, targeting, and transactions. Along with our local partners, YLS is dedicated to bridging the gap between global medical technologies and the Asian market.

Navigating Entry into China and Japan Markets and Access to Additional Resources and Funding.

Fund Management

YAFO Capital Healthcare Fund actively fund innovative companies within all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health, partnering with those that have strong growth potential in China and Japan market. Our mission is to bridge the gap between undercapitalized life science projects, companies, and investors through direct investment and/or licensing/co-development arrangements.

View YAFO Fund Management

Our Team Members

Our expertise allows YAFO Capital to deliver added value throughout all aspects of a transaction – opportunity identification, strategy development, deal planning, execution, negotiations, structuring, and closing.

Sean Jiang, CFA

Founder & CEO
20 years of Wall Street experience, banking & investment of technologies

Kun Tao, CFA

Partner, Head of U.S. Business
20+ years of Wall Street experience in equity research and cross-border pharma licensing/investment

Fan Zheng

Managing Director
Extensive involvement and expertise in 30+ global life science licensing & cross border financial transactions

Lei Cai

More than 20 years’ experience in investment banking

William Yao

30 years+ healthcare experience, including 7+ years in AstraZeneca China

Events & News

View More